Clinical Studies Management
Our flagship service. Insight is the CRO of choice in Egypt for sponsors who expect their study to be delivered on schedule and to the highest standard, with one dedicated team guiding it from medical evaluation and protocol development through to the final clinical study report.
The outcome of a clinical study is determined by its execution: the right sites, achievable recruitment, reliable data and timely approvals. We take ownership of these critical details, allowing you to concentrate on the science and the strategic decisions.
Insight CRO is considered one of the best CROs in Egypt. We combine in-depth expertise in the challenges of conducting clinical research locally and executing studies at Egyptian sites with extensive experience in monitoring global, multinational clinical studies to international standards.
Every study is led by a senior project manager who oversees it from planning and start-up through conduct and close-out. As your single point of accountability, they align sponsors, investigators, sites, ethics committees and the authority around one integrated plan.
Our understanding of the Egyptian research landscape is first-hand: the approval pathway, the institutions and investigators, and the realistic duration of each stage. This insight is why our timelines and budgets hold, and why sponsors entrust us with study after study.
Above all, we remain closely engaged. You will always have a named project lead who is readily reachable, responds promptly and is available beyond office hours whenever your study requires it. That is the standard of a premium CRO partnership.

Expertise across the full spectrum of clinical research
From early-phase trials to large real-world programmes, every study receives the same scientific rigour and operational discipline.
Phase I to Phase III trials
Interventional studies of new medicines and new indications, from early clinical pharmacology through to pivotal trials that support registration.
Phase IV and post-marketing studies
Post-approval studies that strengthen the evidence on effectiveness, safety and use in routine clinical practice.
Bioequivalence and clinical pharmacology
Studies comparing formulations and characterising pharmacokinetic behaviour, supporting generic and innovative product registration.
Observational and real-world studies
Registries, cohort and cross-sectional studies, and retrospective chart reviews that capture outcomes in routine care.
Post-authorisation safety studies
Studies mandated by the authority or initiated by the sponsor to characterise or confirm the safety profile of an authorised medicine.
Medical device studies
Clinical investigations and post-market clinical follow-up for medical devices.
Investigator-initiated studies
Comprehensive support for investigators and academic institutions leading their own research, from protocol to publication.
Local arms of multinational studies
Egyptian sites within global programmes, conducted under the sponsor’s procedures while we manage local approvals, sites and logistics.
A partnership tailored to your programme
Whether you require a full-service CRO or specialist support for part of your programme, you benefit from the same experienced team and the same commitment to quality.
- 01
Full-service partnership
A single team assumes responsibility for the entire study, from feasibility and protocol to the final report and publication, under one contract, one integrated plan and one named project lead.
- 02
Functional services
Select the specific services you require, such as monitoring, data management, medical writing or regulatory submissions, to complement your internal team or another CRO.
- 03
Local partner for global sponsors
For international sponsors and CROs, we serve as the local team in Egypt, managing approvals, sites, monitoring and logistics to your global standards.
Comprehensive support at every stage, from Phase I to Phase IV
- 01
Feasibility and planning
Every commitment is validated before it is made. We evaluate the patient population, competing studies, site capacity and approval timelines in Egypt, and agree a recruitment plan, timeline and budget that are genuinely achievable.
- 02
Protocol and scientific advice
Our medical team refines the research question, design, endpoints and eligibility criteria, and provides scientific advice wherever the design calls for it. We author the protocol and informed consent documents to be clear for participants and ready for review.
- 03
Investigator and site selection
We identify principal investigators and sites with the appropriate patient population, expertise and infrastructure, qualify each one in person, and agree evidence-based recruitment targets with every investigator.
- 04
Regulatory and ethics approvals
We compile and submit the study dossier to the research ethics committees, the Supreme Council for Clinical Research Ethics and the Egyptian Drug Authority, and manage every enquiry on your behalf through to approval.
- 05
Study start-up
Site contracts and budgets, the trial master file, investigational product supply and storage, laboratory and vendor arrangements, study tools and investigator training are fully in place before the first participant is screened. Each site opens with a formal initiation visit.
- 06
Medical oversight and safety
Our medical team addresses eligibility enquiries and reviews adverse events and protocol deviations as they arise. Serious adverse events are assessed and reported to the sponsor, the ethics committees and the authority within regulatory timelines.
- 07
Clinical monitoring
Our monitors visit sites on a risk-based schedule, verify source data, review consent and essential documents, and confirm protocol compliance and participant safety. Findings are escalated early and tracked through to resolution.
- 08
Data management
Study data is captured in Insight EDC, our electronic data capture system. Our data managers validate data continuously, resolve queries with sites and maintain the database in an analysis-ready state throughout.
- 09
Sponsor reporting
You have complete visibility of your study at all times. Regular progress reports cover recruitment, site performance, data status, safety, timelines and budget, and we meet with you to agree any corrective action.
- 10
Statistical analysis and interim reporting
Our biostatisticians author the statistical analysis plan, conduct interim analyses where the protocol specifies them, and prepare interim reports for the sponsor and the data monitoring committee.
- 11
Medical writing
Protocol amendments, investigator’s brochure updates, safety narratives and clinical evaluation reports are prepared by our medical writers to a high standard of clarity and compliance.
- 12
Study close-out
We reconcile all documentation and investigational product, close each site formally, archive the trial master file, and notify the ethics committees and the authority of the end of the study.
- 13
Clinical study report and publication
We author the final clinical study report in accordance with ICH E3, and prepare the manuscript for a peer-reviewed journal following CONSORT and ICMJE recommendations.
The guidelines that govern our work, in Egypt and worldwide
Our procedures are kept current with the latest international and Egyptian requirements, and our team is retrained whenever they evolve.
ICH E6 (R3) Good Clinical Practice
The international standard for the design, conduct and reporting of clinical trials.
ICH E8 (R1), E9 and E3
General considerations for clinical studies, statistical principles and the structure of clinical study reports.
Declaration of Helsinki
The World Medical Association’s ethical principles for research involving human participants, in its 2024 revision.
Law No. 214 of 2020 and its executive regulations
Egypt’s legislation governing medical and clinical research, including the requirements of the Supreme Council for Clinical Research Ethics.
Egyptian Drug Authority requirements
EDA guidance on clinical trial approval, investigational products, safety reporting and inspections.
CIOMS, CONSORT and ICMJE
International ethical guidelines for health research and standards for reporting and publishing trial results.
Specialist services within every study
Protocol Development
Protocols, consent forms and essential study documents designed for approval and flawless execution.
Site Selection and Management
Rigorously selected investigators and sites, supported from feasibility to close-out.
Clinical Monitoring
Risk-based monitoring to local and global multinational standards.
Data Management and Biostatistics
Validated data on Insight EDC and statistical analysis that withstands scrutiny.
Medical Writing
Clinical, regulatory and publication documents of the highest scientific standard.
